Continuation of follow-up of DES-exposed cohorts

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500026C
Awardee
Awarding agency
Obligated
$1,220,034

Award facts

Opportunity
  • N02CP5101258 Solicitation number
Contract value 100% obligated
$1,220,033.73 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Roxbury, MA 02118, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$264,380
Funding Only Action P00008 -$874
Other Administrative Action P00007 -$909
Exercise an Option P00006 $337,897
Exercise an Option 5 $365,255
Change Order 4 $105,294
Other Administrative Action 3 $223,681
Other Administrative Action 2 $0
Exercise an Option 1 $227,814
Original award $226,256

About this award

The National Cancer Institute awarded a $1.22 million definitive contract to Trustees Of Boston University for continuation of follow-up of DES-exposed cohorts on September 22, 2015, under cost-no-fee pricing with no set-aside.

Place of performance is Roxbury, MA. The contract ceiling value is $1,220,033.73 with an ultimate completion date of September 21, 2020.

Quick answers

Who was awarded contract HHSN261201500026C?

HHSN261201500026C was awarded to Trustees Of Boston University by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500026C worth?

The government has obligated $1,220,034 on HHSN261201500026C.

Was contract HHSN261201500026C competed?

The extent of competition for HHSN261201500026C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award